13G Filing: Great Point Partners and PTC Therapeutics Inc. (PTCT)

Page 5 of 10

Page 5 of 10 – SEC Filing

CUSIP
No.
69366J200
13G Page
5 of 9 Pages
Item 1.
(a) Name of Issuer
PTC Therapeutics Inc.
(b) Address of Issuer’s Principal Executive Offices
100 Corporate Court, South Plainfield, NJ 07080-2449
Item 2.
(a) Name of Person Filing
Great Point Partners, LLC
Dr. Jeffrey R. Jay, M.D.
Mr. David Kroin
The Reporting Persons have entered into a Joint Filing
Agreement, dated June 16, 2017, a copy of which is filed with this Schedule 13G as Exhibit A, pursuant to which the Reporting
Persons have agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.
(b) Address of Principal Business Office, or if none, Residence
The address of the principal business office of each of the Reporting
Persons is
165 Mason Street, 3rd Floor
Greenwich, CT 06830
(c) Citizenship
Great Point Partners, LLC is a limited liability company
organized under the laws of the State of Delaware. Dr. Jeffrey R. Jay, M.D. is a citizen of the United States. Mr. David Kroin
is a citizen of the United States.
(d) Title of Class of Securities
Common Stock
(e) CUSIP Number
69366J200
Item 3. If this statement is filed pursuant to §240.13d-1(b) or 240.13d.2(b) or (c), check whether the person
filing is a:
Not Applicable.
(a) o Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o)
(b) o Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) o Insurance company as defined in Section 3(a)(19) of the Act (15. U.S.C. 78c).
(d) o Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e) x An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

Follow Ptc Therapeutics Inc. (NASDAQ:PTCT)

Page 5 of 10